<?xml version='1.0' encoding='utf-8'?>
<document id="6781810"><sentence text="Mechanism of valproate-phenobarbital interaction in epileptic patients."><entity charOffset="13-22" id="DDI-PubMed.6781810.s1.e0" text="valproate" /></sentence><sentence text="Valproate effects on phenobarbital biodisposition were examined in a search for the mechanisms of the valproate-induced elevation of plasma phenobarbital during antiepileptic therapy"><entity charOffset="0-9" id="DDI-PubMed.6781810.s2.e0" text="Valproate" /><entity charOffset="102-111" id="DDI-PubMed.6781810.s2.e1" text="valproate" /><pair ddi="false" e1="DDI-PubMed.6781810.s2.e0" e2="DDI-PubMed.6781810.s2.e0" /><pair ddi="false" e1="DDI-PubMed.6781810.s2.e0" e2="DDI-PubMed.6781810.s2.e1" /></sentence><sentence text=" The study involved patients who were treated with phenobarbital alone and phenobarbital plus valproate"><entity charOffset="75-103" id="DDI-PubMed.6781810.s3.e0" text="phenobarbital plus valproate" /></sentence><sentence text=" Several kinetic parameters were determined after a pulse dose of stable isotope-labeled phenobarbital, with plasma phenobarbital levels at a steady state"><entity charOffset="89-102" id="DDI-PubMed.6781810.s4.e0" text="phenobarbital" /></sentence><sentence text=" Plasma elimination of labeled phenobarbital was studied by selected ion monitoring"><entity charOffset="31-44" id="DDI-PubMed.6781810.s5.e0" text="phenobarbital" /></sentence><sentence text=" The addition of valproate to the phenobarbital regimen resulted in elevation of plasma phenobarbital and increase in urinary output of unchanged phenobarbital"><entity charOffset="17-26" id="DDI-PubMed.6781810.s6.e0" text="valproate" /><entity charOffset="34-47" id="DDI-PubMed.6781810.s6.e1" text="phenobarbital" /><entity charOffset="146-159" id="DDI-PubMed.6781810.s6.e2" text="phenobarbital" /><pair ddi="false" e1="DDI-PubMed.6781810.s6.e0" e2="DDI-PubMed.6781810.s6.e0" /><pair ddi="false" e1="DDI-PubMed.6781810.s6.e0" e2="DDI-PubMed.6781810.s6.e1" /><pair ddi="false" e1="DDI-PubMed.6781810.s6.e0" e2="DDI-PubMed.6781810.s6.e2" /><pair ddi="false" e1="DDI-PubMed.6781810.s6.e1" e2="DDI-PubMed.6781810.s6.e1" /><pair ddi="false" e1="DDI-PubMed.6781810.s6.e1" e2="DDI-PubMed.6781810.s6.e2" /></sentence><sentence text=" There was no effect on urinary pH" /><sentence text=" The rise in plasma phenobarbital was paralleled by lengthening of phenobarbital elimination half-life while the decrease of plasma phenobarbital clearance paralleled the decrease in phenobarbital elimination rate constant" /><sentence text=" These findings suggest that inhibition of phenobarbital metabolism by valproate is the mechanism for this clinically important drug-drug interaction"><entity charOffset="43-56" id="DDI-PubMed.6781810.s9.e0" text="phenobarbital" /><entity charOffset="71-80" id="DDI-PubMed.6781810.s9.e1" text="valproate" /><pair ddi="false" e1="DDI-PubMed.6781810.s9.e0" e2="DDI-PubMed.6781810.s9.e0" /><pair ddi="false" e1="DDI-PubMed.6781810.s9.e0" e2="DDI-PubMed.6781810.s9.e1" /></sentence><sentence text="" /></document>